Streetbeat News

EQC

Equity Commonwealth

https://www.eqcre.com

Industry

REIT - Office

Equity Commonwealth (NYSE: EQC) is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties in the United States. EQC's same property portfolio is comprised of 4 properties and 1.5 million square feet.

Open

20.13

Mkt cap

2.2B

Volume

829K

High

20.19

P/E Ratio

52.95

52-wk high

21.00

Low

20.06

Div yield

N/A

52-wk low

17.93

Equity Commonwealth (NYSE:EQC) reported Q3 2024 earnings of $0.25 per share, surpassing the analyst estimate of $0.23. Sales reached $13.988 million, significantly beating the $7.070 million estimate, despite an 8.05% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 8:27 pm

Equity Commonwealth reported Funds From Operations (FFO) of $0.24 for Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:30 pm

Activist investor Indaba Capital Management has reportedly amassed a stake in Equity Commonwealth (EQC), according to Bloomberg. This move could signal potential changes or strategic shifts within the company.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 7:08 pm

Equity Commonwealth (EQC) has announced plans to repurchase up to an additional $150 million of its common shares from July 1, 2024, through June 30, 2025, under its existing share repurchase program. The company still has $93 million remaining under its prior authorization, which expires on June 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 9:49 pm

Equity Commonwealth (NYSE:EQC) reported Q1 2024 FFO of $0.25 per share, meeting analyst estimates, and sales of $15.190M, surpassing the $8.206M estimate. This represents an 8.7% increase in earnings per share and an 85.11% beat on sales estimates compared to the same period last year, despite a slight 2.48% decrease in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:28 pm

Equity Commonwealth (NYSE:EQC) reported Q4 2023 FFO of $0.26 per share, meeting analyst estimates, with sales of $15.15M surpassing the $8.48M forecast by 78.63%. However, this represents a 4.06% decrease from the previous year's sales of $15.79M.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 9:51 pm

Numerous companies are scheduled to report their earnings on February 12, 2024, with expectations spanning from losses to significant profits across various sectors. Key reports include Goodyear Tire & Rubber with expected earnings of $0.36 per share on $5.39 billion revenue, and Avis Budget Group projecting earnings of $4.15 per share on $2.81 billion revenue. The diversity in performance indicators reflects a broad economic landscape, potentially influencing market movements.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 10:21 am

The article highlights three office REITs with high dividend yields for investors interested in real estate investments without direct property management. Equity Commonwealth (EQC) leads with a 27.35% yield, focusing on office properties in Colorado, Texas, and Washington, D.C. Office Properties Income Trust (OPI) offers a 14.28% yield, with a portfolio leaning towards government and corporate single tenants. Brandywine Realty Trust (BDN) has an 11.33% yield, concentrating on urban and transit-oriented office properties in Philadelphia, Austin, and Washington, D.C.

Portfolio Pulse from Chris Bibey

December 23, 2023 | 5:00 pm

Equity Commonwealth (NYSE:EQC) reported Q3 earnings of $0.26 per share, a 100% increase YoY. The company also reported quarterly sales of $15.21 million, beating the analyst consensus estimate of $14.50 million by 4.91% and marking a 0.57% increase YoY.

Portfolio Pulse from mahesh@benzinga.com

October 30, 2023 | 8:34 pm

During Friday's session, 157 stocks hit new 52-week lows. Among the notable companies were Corteva, American Rebel Holdings, Mullen Automotive, and BNY Mellon Strategic. The stocks that created new 52-week lows on Friday included Avangrid, SolarEdge Technologies, Etsy, UGI, Concentrix, Hawaiian Electric Indus, Equity Commonwealth, Forward Air, Cracker Barrel Old, Petco Health and Wellness, JinkoSolar Holding Co, Olaplex Hldgs, Frontier Group Holdings, Impinj, Safehold, Monro, 3D Sys, TDCX, Everbridge, Silk Road Medical, Cassava Sciences, 23andMe Holding, Wolverine World Wide, Avidity Biosciences, Boston Omaha, John Hancock Premium Div, BioLife Solns, Seres Therapeutics, American Well, Materialise, BNY Mellon Strategic, Southland Holdings, Funko, Fate Therapeutics, Citizens Financial Servs, American Lithium, Emergent BioSolutions, PetMed Express, Sutro Biopharma, Hippo Holdings, Largo, Omega Therapeutics, System1, Benson Hill, Eaton Vance Municipal, Vor Biopharma, Star Hldgs, Origin Mat, Joint, NanoString Technologies, Codexis, ContextLogic, Akoustis Technologies, Cano Health, GeneDx Hldgs, Electrovaya, Kezar Life Sciences, ProPhase Labs, Alaunos Therapeutics, Chimerix, Electriq Power Holdings, DZS, Streamline Health Solns, Eargo, Intercure, Prime Number Acquisition, REE Automotive, TD Hldgs, Carmell Therapeutics, Neuronetics, Kaixin Auto Hldgs, Crown Crafts, Airgain, Ohmyhome, Singular Genomics Sys, First Seacoast Bancorp, Sarcos Technology, Coya Therapeutics, Otonomo Technologies, CareCloud, Aterian, PAVmed, Orgenesis, CalAmp, Imperial Ptrl, Fitell, LQR House, Iridex, OMNIQ, Safeguard Scientifics, Lichen China, Origin Agritech, Atreca, Sunlight Finl Hldgs, Yunji, MediaCo Holding, Trio Petroleum, Cineverse, Lucy Scientific Discovery, Remark Hldgs, Shuttle Pharmaceuticals, Hempacco, Finch Therapeutics Gr, Visionary Education Tech, Marpai, Ontrak, Nogin, Adamis Pharmaceuticals, China Jo-Jo Drugstores, ABVC BioPharma, Fangdd Network Group, SeaStar Medical Holding, Yoshiharu Global, Universe Pharmaceuticals, Redhill Biopharma, Jiuzi Hldgs, Power REIT, Soligenix, Eightco Holdings, JanOne, Avalo Therapeutics, Yield10 Bioscience, Aditxt, Salarius Pharmaceuticals, China Pharma Holding, OpGen, Akanda, Harbor Custom Dev, Biocept, NeuBase Therapeutics, Ucommune International, INVO Bioscience, Esports Entertainment, American Rebel Holdings.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:01 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.